Analysis of Parkinson's disease brain–derived DNA for alpha-synuclein coding somatic mutations

Although alpha‐synuclein (SNCA) is crucial to the pathogenesis of Parkinson's disease (PD) and dementia with Lewy bodies (DLB), mutations in the gene appear to be rare. We have recently hypothesized that somatic mutations in early development could contribute to PD.

[1]  Kun Zhang,et al.  Massively parallel polymerase cloning and genome sequencing of single cells using nanoliter microwells , 2013, Nature Biotechnology.

[2]  Evan Z. Macosko,et al.  Our Fallen Genomes , 2013, Science.

[3]  Z. Israel,et al.  The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease. , 2013, Parkinsonism & related disorders.

[4]  Ira M. Hall,et al.  Mosaic Copy Number Variation in Human Neurons , 2013, Science.

[5]  Deborah A Nickerson,et al.  Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS). , 2013, Human molecular genetics.

[6]  James Hadfield,et al.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension , 2013, Nature Genetics.

[7]  J. Lupski.  Genome Mosaicism—One Human, Multiple Genomes , 2013, Science.

[8]  C. Walsh,et al.  Somatic Mutation, Genomic Variation, and Neurological Disease , 2013, Science.

[9]  Annabelle L. Fonseca,et al.  Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism , 2013, Nature Genetics.

[10]  T. Gasser,et al.  Parkinson's disease: Is it all in the genes? , 2013, Movement disorders : official journal of the Movement Disorder Society.

[11]  C. Klein,et al.  The many faces of alpha‐synuclein mutations , 2013, Movement disorders : official journal of the Movement Disorder Society.

[12]  A. Schapira,et al.  Somatic Alpha-Synuclein Mutations in Parkinson's Disease: Hypothesis and Preliminary Data , 2013, Movement disorders : official journal of the Movement Disorder Society.

[13]  Leslie G. Biesecker,et al.  A genomic view of mosaicism and human disease , 2013, Nature Reviews Genetics.

[14]  T. Wieland,et al.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension , 2013, Nature Genetics.

[15]  J. Hardy,et al.  α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? , 2013, Acta Neuropathologica.

[16]  D. Absher,et al.  Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime , 2012, Journal of Medical Genetics.

[17]  M. Gerstein,et al.  Somatic copy-number mosaicism in human skin revealed by induced pluripotent stem cells , 2012, Nature.

[18]  S. Rosset,et al.  Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. , 2012, Parkinsonism & related disorders.

[19]  J. Lupski.  Brain Copy Number Variants and Neuropsychiatric Traits , 2012, Biological Psychiatry.

[20]  Michael P. Snyder,et al.  Extensive genetic variation in somatic human tissues , 2012, Proceedings of the National Academy of Sciences.

[21]  J. Kim,et al.  Postural Instability and Cognitive Dysfunction in Early Parkinson's Disease , 2012, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[22]  Francesca Chiaromonte,et al.  A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome? , 2012, Genome research.

[23]  N. Hattori,et al.  Phenotype of the 202 adenine deletion in the parkin gene: 40 years of follow‐up , 2011, Movement disorders : official journal of the Movement Disorder Society.

[24]  Mohamad Saad,et al.  Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.

[25]  Jeffrey M. Hausdorff,et al.  Gait alterations in healthy carriers of the LRRK2 G2019S mutation , 2011, Annals of neurology.

[26]  M. Farrer,et al.  LRRK2 and Parkinson disease. , 2010, Archives of neurology.

[27]  K. Mrasek,et al.  Early Embryonic Chromosome Instability Results in Stable Mosaic Pattern in Human Tissues , 2010, PloS one.

[28]  S. Frank.  Somatic evolutionary genomics: Mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration , 2010, Proceedings of the National Academy of Sciences.

[29]  Carl T Wittwer,et al.  High‐resolution DNA melting analysis: advancements and limitations , 2009, Human mutation.

[30]  Y Ben-Shlomo,et al.  The effect of onset age on the clinical features of Parkinson’s disease , 2009, European journal of neurology.

[31]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[32]  Nir Giladi,et al.  The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. , 2007, Parkinsonism & related disorders.

[33]  Nobutaka Hattori,et al.  Prognosis of Parkinson's disease: Time to stage III, IV, V, and to motor fluctuations , 2006, Movement disorders : official journal of the Movement Disorder Society.

[34]  K. Marder,et al.  Contribution of aging to the severity of different motor signs in Parkinson disease. , 2005, Archives of neurology.

[35]  R. Pamphlett.  Somatic mutation: a cause of sporadic neurodegenerative diseases? , 2004, Medical hypotheses.

[36]  T. Iwatsubo,et al.  α‐Synuclein Accumulates in Purkinje Cells in Lewy Body Disease but not in Multiple System Atrophy , 2003 .

[37]  I Litvan,et al.  Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study , 2000, Neurology.

[38]  E. van der Velde,et al.  Clinical course of patients with idiopathic Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.

[39]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[40]  Hideo Fujiwara,et al.  Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. , 2003, Journal of neuropathology and experimental neurology.